Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.03
+0.19 (3.25%)
Aug 3, 2026, 11:40 AM EDT - Market open
Evolus Market Cap
Evolus has a market cap or net worth of $397.1 million as of August 3, 2026. Its market cap has decreased by -32.69% in one year.
Market Cap
397.10M
Enterprise Value
512.22M
1-Year Change
-32.69%
Ranking
Category
Stock Price
$6.03
ChartMarket Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $397.10M, an increase of 46.37%. That is a compound annual growth rate of 4.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 397.10M | -7.89% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tilray Brands | 650.27M |
| Aquestive Therapeutics | 476.77M |
| BioAge Labs | 464.98M |
| Kamada | 418.44M |
| Canopy Growth | 388.19M |
| Emergent BioSolutions | 375.36M |
| Akebia Therapeutics | 355.44M |
| Organogenesis Holdings | 304.32M |